Age-related macular degeneration and apoptosis;Dégénérescence maculaire liée à l'âge et apoptose

Journal Francais d'Ophtalmologie

Volumn 26, Issue 3, 2003, Pages 307-311

  Haddad, W M ^a   Coscas, G ^a   Soubrane, G ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Age related macular degeneration; Apoptosis; Choroidal neovascular membranes; Oxidative stress

Indexed keywords

APOPTOSIS; DRUSEN; HUMAN; OCULAR FIBROSIS; OXIDATIVE STRESS; PATHOGENESIS; PIGMENT CELL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT PLANNING; AGED; AGING; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHOTORECEPTOR; PHYSIOLOGY; RETINA MACULA DEGENERATION;

AGED; AGING; APOPTOSIS; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; OXIDATIVE STRESS; PHOTORECEPTORS;

EID: 0038050582     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Survey. Am J Epidemiol, 1988;128:700-10.
2. Eye Disease Case-Control Study Group. Antioxydant status and neovascular agerelated macular degeneration. Arch Ophthalmol, 1993;11:104-9.
3. West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S et al. Are antioxidants or supplements protective for agerelated macular degeneration? Arch Ophthalmol, 1994;112:222-7.
4. Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz-Sapuntzakis M et al. Serum antioxidants and agerelated macular degeneration in a population-based case-control study. Arch Ophthalmol, 1995;113:1518-23.
5. Delcourt C, Cristol JP, Leger CL, Descomps B, Papoz L. Associations of antioxidants enzymes with cataract and age-related macular degeneration. The POLA Study. Pathologies Oculaires Liées à l'Âge. Ophthalmology, 1999;106:215-22.
6. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol, 1995;39:367-74.
7. Klein R, Klein BE, Linton KL, Demets DL. The Beaver Dam Eye study. The relation of age-related macular degeneration to smoking. Am J Epidemiol, 1993;137:190-200.
8. Vingerling JR, Hofman A, Groobee DE, De Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol, 1996;115:1193-6.
9. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE et al. Risk factors for age-related macular degeneration. Pooled findings from three continents. Ophthalmology, 2001;108:697-704.
10. Brunk UT, Wihlmark U, Wrigstad A, Roberg K, Nilson SE. Accumulation of lipofuscin within retinal pigment epithelial cells results in enhanced sensitivity to photo-oxidation. Gerontology, 1995;41:201-12.
11. Wihlmark U, Wrigstad A, Roberg K, Nilson SE, Brunk UT. Lipofuscin accumulation in cultured retinal pigment epithelial cells causes enhanced sensitivity to blue light irradiation. Free Radic Biol Med, 1997;22:1229-34.
12. Barak A, Morse LS, Goldkorn T. Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 2001;42:247-54.
13. Cai J, Wu M, Nelson K, Jones DP, Sternberg P Jr. Oxidant induced apoptosis in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 1999;40:959-66.
14. Hafezi F, Marti A, Munz K, Reme CE. Light-induced apoptosis. Differential timing in the retina and pigment epithelium. Exp Eye Res, 1997;64:963-70.
15. Osborne NN, Cazevieille C, Pergande G, Wood J. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine. Invest Ophthalmol Vis Sci, 1997;38:1390-400.
16. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M et al. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest, 1196;98:1667-75.
17. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci, 1994;1994;35:3974-9.
18. Wallace DC, Brown MD, Melov S, Graham B, Lott M. Mitochondrial biology, degenerative diseases and aging. Biofactors, 1998;7:187-90.
19. Brierley EJ, Johnson MA, Lightowlers RN, James OFW, Tumbull DM. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol, 1998;43:217-23.
20. Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW. An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle. Mutat Res, 1998;421:27-36.
21. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta, 1998;1366:151-65.
22. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TL, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science, 1997;275:1129-32.
23. Cai J, Yang J, Jones DP. Mitochondrial control of cytochrome c: the role of cytochrome c. Biochim Biophys Acta, 1998;1366:139-50.
24. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apfa1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997;91:479-89.
25. Zou H, Li Y, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem, 1999;274:11549-56.
26. Mancini M, Nicholson DW, Roy S, Thornberry NA, Peterson EP, Casciola-Rosen LA, Rosen A. The caspase-3 precusor has a cytosolic and mitochondrial distribution: implication for apoptotic signaling. J Cell Biol, 1998;140:1485-95.
27. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdidiczka D et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med, 1998;187:1261-71.
28. Hirsh T, Susin SA, Marzo I, Marchetti P, Zamzami N, Kroemer G. Mitochondrial permeability transition in apoptosis and necrosis. Cell Biol Toxicol, 1998;14:141-5.
29. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Brenner C, Larochette N et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med, 1999;189:381-94.
30. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 1999;397:441-6.
31. Harman D. Ageing: a theory based on free radical and radiation chemistry. J Gerontol, 1956;11:298-300.
32. Shignenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA, 1994;91:10771-8.
33. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds and rhodopsin mutant mice. Neuron, 1993;11:595-605.
34. Portera-Cailliau C, Sung CH, Nathans J, Adler R. Apoptosis photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA, 1994;91:974-8.
35. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic. Evidence for selective vulnerability of rods in central retina. Invest Ophthalmol Vis Sci, 1993;34:3278-96.
36. Mohand-Said S, Deudon-Combe A, Hicks D, Simonuttti M, Forster V, Fintz AC. Normal retina releases a diffusible factor stimulating cone survival in the retinal degeneration mouse. Proc Natl Acad Sci USA, 1998;95:8357-62.
37. Lambooij AC, Kliffen M, Kuijpers RW, Houtsmuller AB, Broerse JJ, Mooy CM. Apoptosis is present in the primate macula at all ages. Graefes Arch Clin Exp Ophthalmol, 2000;238:508-14.
38. Burns RP, Feeney-Burns L. Clinico-morphologic correlations of drusen of Bruch's membrane. Trans Am Ophthalmol Soc, 1980;78:206-25.
39. Ishibashi T, Sorgente N, Patterson R, Ryan S. Pathogenesis of drusen in the primate. Invest Ophthalmol Vis Sci, 1986;27:184-93.
40. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol, 1984;102:1640-2.
41. Hinton DR, He S, Lopez PF. Apoptosis in surgically excised choroidal neovascular membranes in age-related macular degeneration. Arch Ophthalmol, 1998;116:203-9.
42. Kaplan HJ, Leibole MA, Tezel T, Ferguson TA. Fas ligand (CD95 ligand) controls angiogenesis beneath the retina. Nat Med, 1999;5:292-7.
43. Wiezorrek R, Schäfer H, Bialasiewicz AA, Richard G. Programmed cell death (apoptosis) in excised subretinal neovascularization. Ophthalmologe, 2000;97:79-83.
44. Esser P, Heimann K, Abts H, Fontana A, Weller M. CD95 (Fas/APO-1) antibody mediated apoptosis of human retinal pigment epithelial cells. Biochem Biophys Res Commun, 1995;213:1026-34.
45. Age-related Eye Disease Study Research Group. A randomised, placebo controlled, clinical trial of high dose supplementation with vitamins C and E and beta carotene for age-related macular degenration and vision loss: AREDS report no.8. Arch Ophthalmol, 2001;119:1417-36.
46. Renno RZ, Delori FC, Holzer RA, Gragoudas ES, Miller JW. Invest Ophthalmol Vis Sci, 2000;41:3963-71.